Baxter Reports First-Quarter 2024 Results
May 03, 2024
May 03, 2024
DEERFIELD, Illinois, May 3 (TNSres) -- Baxter International, a health care company that focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions, issued the following news release on May 2, 2024:
* * *
* First-quarter sales from continuing operations of $3.59 billion increased 2% on a reported basis and 3% on a constant currency basis, exceeding the company's previously issued guidance1
* Firs . . .
* * *
* First-quarter sales from continuing operations of $3.59 billion increased 2% on a reported basis and 3% on a constant currency basis, exceeding the company's previously issued guidance1
* Firs . . .